Notch Signaling and Malignant Melanoma

  • Cornelia S. L. Müller

Abstract

Increasing evidence indicates that Notch signaling contributes to physiologic processes, including development, differentiation and tumorigenesis, either as a tumor promoter or suppressor depending on the cellular context, level of expression and cross-talk with other signaling systems. Notch signalling has been implicated in the regulation of self-renewal of adult stem cells and differentiation of precursors along a specific cell line in normal embryonic development and organogenesis. There is also evidence that signaling through Notch receptors regulates cell proliferation and cell survival in several types of cancer including malignant melanoma, with opposing results depending on the tissue context. Tumor progression/metastasis of malignant melanoma are complicated processes that require multiple cellular events, including cell proliferation, survival, migration and invasion. Notch signaling appears to be a promising system for new therapeutic targets for the treatment of melanoma and perhaps the prevention of melanoma metastasis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Panelos J, Batistatou A, Paglierani M et al. Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol 2009; 22(7):959–68.CrossRefGoogle Scholar
  2. 2.
    Panelos J, Massi D. Emerging role of Notch signaling in epidermal differentiation and skin cancer. Cancer Biol Ther 2009; 8(21):1986–93.PubMedCrossRefGoogle Scholar
  3. 3.
    Moriyama M, Durham AD, Moriyama H et al. Multiple roles of Notch signaling in the regulation of epidermal development. Dev Cell 2008; 14(4):594–604.CrossRefGoogle Scholar
  4. 4.
    Iso T, Kedes L, Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194(3):237–55.PubMedCrossRefGoogle Scholar
  5. 5.
    Moriyama M, Osawa M, Mak SS, et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol 2006; 173(3):333–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Schouwey K, Beermann F. The Notch pathway: hair graying and pigment cell homeostasis. Histol Histopathol 2008; 23(5):609–19.PubMedGoogle Scholar
  7. 7.
    Massi D, Tarantini F, Franchi A et al. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Mod Pathol 2006; 19(2):246–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Osawa M, Fisher DE. Notch and melanocytes: diverse outcomes from a single signal. J Invest Dermatol 2008; 128(11):2571–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 2003; 3(10):756–67.PubMedCrossRefGoogle Scholar
  10. 10.
    Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 2006; 580(12):2860–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Diao JS, Zhang X, Xia WS et al. Aberrant Notch signaling: a potential pathomechanism of vitiligo. Med Hypotheses 2009; 73(1):70–2.CrossRefGoogle Scholar
  12. 12.
    Hu XB, Feng F, Wang YC et al. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009; 11(1):32–8.PubMedGoogle Scholar
  13. 13.
    Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003; 3(8):559–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Bedogni B, Warneke JA, Nickoloff BJ et al. Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 2008; 118(11):3660–70.PubMedCrossRefGoogle Scholar
  15. 15.
    Okuyama R, Tagami H, Aiba S. Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 2008; 49(3):187–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Hirobe T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005; 18(1):2–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Schouwey K, Delmas V, Larue L et al. Notch1 and Notch2 receptors influence progressive hair graying in a dose-dependent manner. Dev Dyn 2007; 236(1):282–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Balint K, Xiao M, Pinnix CC et al. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005; 115(11):3166–76.PubMedCrossRefGoogle Scholar
  19. 19.
    Fitzgerald K, Harrington A, Leder P. Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 2000; 19(37):4191–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Bhat KM, Maddodi N, Shashikant C, et al. Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling. Nucleic Acids Res 2006; 34(13):3819–32.PubMedCrossRefGoogle Scholar
  21. 21.
    Müller CSL RS, Denzer N, Tilgen W et al. Analysis of the NOTCH-signaling pathway in malignant melanoma. Exp Dermatol 2009.Google Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2012

Authors and Affiliations

  • Cornelia S. L. Müller
    • 1
  1. 1.Department of DermatologyThe Saarland University HospitalHomburgGermany

Personalised recommendations